Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3591)
All Articles published online
|
Sep 15, 2004 (publication date) through Nov 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
Li DQ, Wang ZB, Bai J, Zhao J, Wang Y, Hu K, Du YH. Effects of mifepristone on proliferation of human gastric adenocarcinoma cell line SGC-7901 |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v10/i18/2628.htm |
| Number | Citing Articles |
| 1 |
Jerome H Check. The role of progesterone and the progesterone receptor in cancer. Expert Review of Endocrinology & Metabolism 2017; 12(3): 187 doi: 10.1080/17446651.2017.1314783
|
| 2 |
Alejandra Chávez-Riveros, Mariana Garrido, María Teresa Ramírez Apan, Armando Zambrano, Mario Díaz, Eugene Bratoeff. Synthesis and cytotoxic effect on cancer cell lines and macrophages of novel progesterone derivatives having an ester or a carbamate function at C-3 and C-17. European Journal of Medicinal Chemistry 2014; 82: 498 doi: 10.1016/j.ejmech.2014.06.008
|
| 3 |
Giulia Cossu, Marc Levivier, Roy Thomas Daniel, Mahmoud Messerer. The Role of Mifepristone in Meningiomas Management: A Systematic Review of the Literature. BioMed Research International 2015; 2015: 1 doi: 10.1155/2015/267831
|
| 4 |
Jerome H. Check, Diane L. Check. The role of progesterone and the progesterone receptor in cancer: progress in the last 5 years. Expert Review of Endocrinology & Metabolism 2023; 18(1): 5 doi: 10.1080/17446651.2023.2166487
|
| 5 |
Heather E. Kapperman, Alicia A. Goyeneche, Carlos M. Telleria. Mifepristone inhibits non-small cell lung carcinoma cellular escape from DNA damaging cisplatin. Cancer Cell International 2018; 18(1) doi: 10.1186/s12935-018-0683-z
|
| 6 |
Yu Gao, Songen Gu, Yingying Zhang, Xiaodong Xie, Ting Yu, Yusheng Lu, Yewei Zhu, Wenge Chen, Huijuan Zhang, Haiyan Dong, Patrick J. Sinko, Lee Jia. The Architecture and Function of Monoclonal Antibody‐Functionalized Mesoporous Silica Nanoparticles Loaded with Mifepristone: Repurposing Abortifacient for Cancer Metastatic Chemoprevention. Small 2016; 12(19): 2595 doi: 10.1002/smll.201600550
|
| 7 |
Mariana Segovia-Mendoza, Rafael Jurado, Roser Mir, Luis A Medina, Heriberto Prado-Garcia, Patricia Garcia-Lopez. Antihormonal agents as a strategy to improve the effect of chemo-radiation in cervical cancer: in vitro and in vivo study. BMC Cancer 2015; 15(1) doi: 10.1186/s12885-015-1016-4
|
| 8 |
Mariana Garrido, Marisa Cabeza, Francisco Cortés, José Gutiérrez, Eugene Bratoeff. Cytotoxic effect of novel dehydroepiandrosterone derivatives on different cancer cell lines. European Journal of Medicinal Chemistry 2013; 68: 301 doi: 10.1016/j.ejmech.2013.02.031
|
| 9 |
Jianzhong Chen, Jichuang Wang, Jingwei Shao, Yu Gao, Jianguo Xu, Suhong Yu, Zhenhua Liu, Lee Jia. The Unique Pharmacological Characteristics of Mifepristone (RU486): From Terminating Pregnancy to Preventing Cancer Metastasis. Medicinal Research Reviews 2014; 34(5): 979 doi: 10.1002/med.21311
|
| 10 |
Alicia A Goyeneche, Carlos M Telleria. Antiprogestins in gynecological diseases. REPRODUCTION 2015; 149(1): R15 doi: 10.1530/REP-14-0416
|
| 11 |
Jirapat Namkaew, Jun Zhang, Norio Yamakawa, Yoshimasa Hamada, Kazue Tsugawa, Miho Oyadomari, Masato Miyake, Toyomasa Katagiri, Seiichi Oyadomari. Repositioning of mifepristone as an integrated stress response activator to potentiate cisplatin efficacy in non-small cell lung cancer. Cancer Letters 2024; 582: 216509 doi: 10.1016/j.canlet.2023.216509
|
| 12 |
Alicia A. Goyeneche, Erin E. Seidel, Carlos M. Telleria. Growth inhibition induced by antiprogestins RU-38486, ORG-31710, and CDB-2914 in ovarian cancer cells involves inhibition of cyclin dependent kinase 2. Investigational New Drugs 2012; 30(3): 967 doi: 10.1007/s10637-011-9655-z
|
| 13 |
Aylin Viviana Silva-Ortiz, Eugene Bratoeff, María Teresa Ramírez-Apan, Rocío García-Becerra, David Ordaz-Rosado, Nancy Noyola-Martínez, Rafael Castillo-Bocanegra, David Barrera. Synthesis and biological activity of two pregnane derivatives with a triazole or imidazole ring at C-21. The Journal of Steroid Biochemistry and Molecular Biology 2016; 159: 8 doi: 10.1016/j.jsbmb.2016.02.013
|
| 14 |
Jerome H. Check, Diane L. Check. Drug Repurposing - Molecular Aspects and Therapeutic Applications. 2022; doi: 10.5772/intechopen.93545
|
| 15 |
Alicia A. Goyeneche, Rubén W. Carón, Carlos M. Telleria. Mifepristone Inhibits Ovarian Cancer Cell GrowthIn vitroandIn vivo. Clinical Cancer Research 2007; 13(11): 3370 doi: 10.1158/1078-0432.CCR-07-0164
|